Filana Therapeutics (FLNA) Other Non-Current Assets (2010 - 2021)
Filana Therapeutics (FLNA) posted quarterly Other Non-Current Assets of $399000.0 for Q4 2021, up 100.5% quarter-over-quarter from $199000.0 in Q3 2021.
Filana Therapeutics (FLNA) Other Non-Current Assets (2010 - 2021) Analysis & Trends
Filana Therapeutics' Other Non-Current Assets history runs 11 years deep, the most recent figure standing at $399000.0 for Q4 2021.
- In Q4 2021, Other Non-Current Assets changed N/A year-over-year to $399000.0; the TTM figure through Dec 2021 stood at $399000.0 (changed N/A YoY), while the FY2021 annual figure was $399000.0, changed N/A from the prior year.
- Other Non-Current Assets for Q4 2021 stood at $399000.0, up from $199000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.4 million in Q2 2021, with the low at $12000.0 in Q4 2017.
- The 4-year median for Other Non-Current Assets is $12000.0 (2017), against an average of $193818.2.
- The sharpest annual moves came in 2018 and 2019: Other Non-Current Assets changed 0.0% in 2018, then plunged 60.0% in 2019.
- Filana Therapeutics' Other Non-Current Assets stood at $12000.0 in 2017, then changed by 0.0% to $12000.0 in 2018, then changed by 0.0% to $12000.0 in 2019, then surged by 3225.0% to $399000.0 in 2021.
- Business Quant data shows FLNA's Other Non-Current Assets at $399000.0 in Q4 2021, $199000.0 in Q3 2021, and $1.4 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 399,000.00 |
| Sep 30, 2021 | 199,000.00 |
| Jun 30, 2021 | 1.42 Mn |
| Sep 30, 2019 | 12,000.00 |
| Jun 30, 2019 | 12,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Dec 31, 2018 | 12,000.00 |
| Sep 30, 2018 | 12,000.00 |
| Jun 30, 2018 | 12,000.00 |
| Mar 31, 2018 | 30,000.00 |
| Dec 31, 2017 | 12,000.00 |
| Sep 30, 2016 | 12,000.00 |
| Jun 30, 2016 | 12,000.00 |
| Mar 31, 2016 | 12,000.00 |
| Dec 31, 2015 | 12,000.00 |
| Sep 30, 2015 | 12,000.00 |
| Jun 30, 2015 | 12,000.00 |
| Mar 31, 2015 | 12,000.00 |
| Dec 31, 2014 | 12,000.00 |
| Sep 30, 2014 | 12,000.00 |